• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Jim Cramer

Jim Cramer: Add 'Better Than Feared' to Your Investing Lexicon

Here's the only way to explain why stocks jump like mad if the companies underneath them only perform slightly better than the analysts worried they would.
By JIM CRAMER Jul 25, 2019 | 03:26 PM EDT
Stocks quotes in this article: BMY, CELG, TXN, MMM, GS, JPM, BAC, DOW, ALGN, PYPL

It's time to enter a new term into the lexicon of stock picking: BTF, or better than feared.

We are seeing stocks jump like mad if the companies underneath them are able to do even slightly better than most analysts feared they would.

Bristol-Myers Squibb (BMY) , for example, on Thursday delivered a BTF quarter. The stock of Bristol has been under severe pressure as worries mounted that its still-pending Celgene (CELG) acquisition might be a bust, and that its top selling cancer drug, Opdivo, isn't performing well vs. Merck's Keytruda.

But sales for Opdivo came in better than feared and the revenues from Eliquis -- which is by far the No. 1 blood thinner in the world and is taking share everywhere -- were off the charts. This is even though Bristol delivered unsatisfactory results with Opdivo just on Wednesday night on a study involving non-small cell lung cancer.

Or to put it another way, I don't know a soul, other than perhaps me, who believed that Bristol would even do the estimates, let alone beat and raise, which stands for beat the estimates and raise the forecast.

Wednesday, we saw the same thing with Texas Instruments (TXN) . The Street was thinking that there was no way that the company, heavily levered to the industrial economy, which is so weak, could possibly beat the earnings estimates. But Texan, as we call it because its symbol is TXN, delivered a BTF quarter and the stock rallied 8 points.

Sometimes it's a fine line: 3M (MMM) looked BTF on the surface and the stock jumped $8 in pre-market trading, but then analysts found things they didn't like on the conference call and it gave up all of its gains. You can never judge BTF by the headlines, because management can print numbers -- another technical term for what the earnings, sales and forecasts were -- and the headline machines have no analytical ability to see if the numbers are all done with smoke and mirrors.

Perhaps the best better than feared so far this quarter came from Goldman Sachs (GS) . A combination of a slowdown in trading and a belief that the company's reports had become too episodic, a good followed by a not so good, followed by a terrible set of figures caused many to fret that this could be another blow-up quarter. That's why it had become the cheapest stock in the group as valued by the price-to-earnings ratio, which is the apples to apples method Wall Street uses to compare stocks to each other.

But when Goldman reported, it was totally BTF, because the firm had a much more stable earnings stream than anyone expected. So, even though it wasn't as good as JPMorgan Chase (JPM) or Bank of America (BAC) in terms of profitability, the stock soared 20 points.

Oh, and how about the uglier than feared. Frankly, there aren't many of these, because typically if a company's earnings are feared to be ugly, they are usually ugly, so there's not a lot of gradation.

I was expecting, for example, an ugly quarter from Dow Inc. (DOW) and it gave me an UTE so it got dinged. Not an important category.

Now BTE, BTF and UTF -- better than expected, better than feared and uglier than feared -- must all take a back seat to plain old disappointment. A disappointment, per se, is something that happens to a company's stock when the Street is looking for a consistently good number.

Align Technology (ALGN) , for example, has been the pillar of consistency. It had a slight miss in estimates and forecast, but Align's been priced for perfection for ages. Big disappointment. Same with Paypal (PYPL) , which lowered its forecast, something holders who have seen this one skyrocket were clearly displeased by. That's why they both got clobbered.

With the economy slowing and with the industrials doing poorly, I believe BTF should be part of any analysis. It is only through that prism that you can understand how a stock could go higher on what looks like not so hot numbers.

DOW, GS and JPM are holdings in Jim Cramer's Action Alerts PLUS member club.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Earnings | Stocks | Jim Cramer |

More from Jim Cramer

Jim Cramer: I'll Put My Money With 'Boring but Lucrative' Any Day

Jim Cramer
Sep 29, 2021 1:28 PM EDT

Let's look at that recent downgrade of 'dull' Morgan Stanley and see why exciting is best left for the stadiums and amusement parks -- and not stocks.

Jim Cramer: America's Toughest Job? Finding Workers

Jim Cramer
Sep 28, 2021 12:17 PM EDT

It's the question of our time: Where are the people willing to take on these better paying gigs? Let's see what's going on and what we need to happen.

Jim Cramer: Here's How Analysts Can Be Off By a Wide Margin

Jim Cramer
Sep 24, 2021 12:02 PM EDT

Let's look at the reactions to Nike, Costco and Salesforce to see what happens when they're viewed from a real world perspective.

Jim Cramer: It's Pure Insanity That We Don't Make Chips Here in the U.S.

Jim Cramer
Sep 23, 2021 11:05 AM EDT

While the big guns meet at the White House about the global chip shortage, the president and these companies are approaching this all wrong.

Jim Cramer: Go Ahead, Have a Cow, but I Say Powell and Xi Are Bulls

Jim Cramer
Sep 22, 2021 3:51 PM EDT

We rallied, because China's President Xi and Fed Chair Powell made decisions that they knew would lead to rallies.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • 07:59 PM EDT PAUL PRICE

    Very Good Quarterly Numbers From Bassett Furniture (BSET)

    Bassett Furniture blew right through analysts es...
  • 04:41 PM EDT PAUL PRICE

    First-Half Results - Putrid; Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 mark...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login